Home/Filings/4/0001209191-22-059174
4//SEC Filing

Schelling Chris 4

Accession 0001209191-22-059174

CIK 0001069308other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 4:02 PM ET

Size

4.9 KB

Accession

0001209191-22-059174

Insider Transaction Report

Form 4
Period: 2022-11-29
Schelling Chris
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2022-11-29$1.22/sh+819,672$1,000,0002,712,529 total

Issuer

Acer Therapeutics Inc.

CIK 0001069308

Entity typeother

Related Parties

1
  • filerCIK 0001717241

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 4:02 PM ET
Size
4.9 KB